EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis

Linda Quatrini iD, Cecilia Ciancaglini, Ivan Caiello, Silvia Santopolo, Manuela Pardeo iD, Valentina Matteo, Elena Loricchio, Donato Amodio, Elena Morrocchi, Giulio Olivieri, Paolo Palma, Antonella Insalaco und 8 weitere

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Linda Quatrini und 19 weiteren Autor:innen. Beteiligte Einrichtung: Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Killer Cells, Natural, Immunity, Innate, Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS, Ministero della Salute, Fondazione Umberto Veronesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic juvenile idiopathic arthritis (sJIA) is a chronic childhood disease classically attributed to innate immune cell dysregulation. This study aimed to elucidate the role of innate lymphoid cells (ILCs), including natural killer (NK) cells and helper‐ILCs (hILCs), in sJIA during clinically inactive disease (CID) through phenotypic and functional analysis.

Methods

Peripheral ILCs from children with sJIA during CID receiving interleukin‐1 (IL‐1) inhibitors (n = 40) were analyzed by flow cytometry and compared to 23 healthy children (HC) and 22 patients with unrelated autoinflammatory diseases taking IL‐1 inhibitors. Plasma proteomic profiling was also performed.

Results

Patients with sJIA showed a significant reduction in circulating NK cell frequencies compared to HC, with an increased proportion of CD56 bright NK cells. Although overall hILC frequencies were comparable to HC, ILC1s were increased, whereas ILC precursors were reduced. ILC1 frequency correlated positively with IL‐18 plasma levels, whereas ILC2 frequency correlated negatively. Functional assessments revealed that NK cells from patients with sJIA had variable interferon γ (IFNγ) production upon IL‐18/IL‐12 stimulation, inversely correlating with IL‐18 levels. Additionally, hILCs from these patients showed a specific impairment in IFNγ production despite normal IL‐13 production, potentially linked to decreased IL‐18 receptor α expression in ILC1s. Proteomic analysis confirmed IL‐18 as the most up‐regulated cytokine in sJIA plasma.

Conclusion

Patients with sJIA in CID exhibit significant innate immune abnormalities, including altered ILC subset distribution and impaired IFNγ production, strongly associated with IL‐18 levels. These findings suggest ongoing immune dysregulation despite clinical remission, underscoring a potential role for ILCs and cytokine interaction in sJIA pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, JuvenileKiller Cells, NaturalImmunity, InnateLymphocytesHumansChildMaleFemaleChild, PreschoolInterleukin-18AdolescentPhenotypeInterferon-gammaCase-Control StudiesProteomicsInterleukin-1

Substanzen

Interleukin-18Interferon-gammaInterleukin-1

Autor:innen und Institutionen

  • Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Tumor Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Laboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Division of Rheumatology, ERN RITA Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS and Department of Systems Medicine, University of Rome "Tor Vergata," Rome, Italy.
  • Clinical and Research Unit of Clinical Immunology and Vaccinology, Bambino Gesù Children's Hospital, IRCCS and PhD Program in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome "Tor Vergata," R…

ORCID-Profile: Linda Quatrini, Manuela Pardeo, Arianna De Matteis, Claudia Bracaglia, Fabrizio De Benedetti

Förderung

  • European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS
  • Ministero della Salute
  • Fondazione Umberto Veronesi
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione AIRC per la ricerca sul cancro ETS

Zitieren

APA

Quatrini, L., Ciancaglini, C., Caiello, I., Santopolo, S., Pardeo, M., Matteo, V., Loricchio, E., Amodio, D., Morrocchi, E., Olivieri, G., Palma, P., Insalaco, A., Natale, M. F., De Matteis, A., Tumino, N., Bracaglia, C., Vacca, P., Moretta, L., De Benedetti, F., & Prencipe, G. (2025). Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43217

Vancouver

Quatrini L, Ciancaglini C, Caiello I, Santopolo S, Pardeo M, Matteo V, et al. Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43217

BibTeX
@article{Quatrini2025,
  author = {Quatrini, Linda and Ciancaglini, Cecilia and Caiello, Ivan and Santopolo, Silvia and Pardeo, Manuela and Matteo, Valentina and Loricchio, Elena and Amodio, Donato and Morrocchi, Elena and Olivieri, Giulio and Palma, Paolo and Insalaco, Antonella and Natale, Marco Francesco and De Matteis, Arianna and Tumino, Nicola and Bracaglia, Claudia and Vacca, Paola and Moretta, Lorenzo and De Benedetti, Fabrizio and Prencipe, Giusi},
  title = {Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43217}
}
Kostenlos starten →